Published On: Wed, Oct 19th, 2016

Halyard Health Inc (NYSE:HYH) – Broker Update

Below are the most recently updated broker updates which include ratings and price targets for Halyard Health Inc (NYSE:HYH).

08/10/2016 – Broker: Deutsche Bank Rating: buy New Target: 41 reiteration

08/04/2016 – Broker: Stifel Nicolaus Rating: buy New Target: 38 reiteration

12/18/2015 – Broker: KeyBanc Rating: sector weight newcoverage

11/04/2015 – Broker: JMP Securities Rating: market outperform New Target: 40 reiteration

10/12/2015 – Broker: Morgan Stanley Rating: underweight New Target: 27 downgrade

07/21/2015 – Broker: Raymond James Rating: market perform newcoverage

05/08/2015 – Broker: Zacks Rating: sell downgrade

The average price target from the most recent broker reports is 36.50

The stock increased +0.97% (+0.33) during the last days session, reaching 34.36 and roughly 187178 shares were bought or sold by traders. Halyard Health Inc (NYSE:HYH) has increased by +19.26% over 12 months.

Halyard Health, Inc. seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections. The Medical Devices segment provides a portfolio of product offerings focused on pain management and respiratory and digestive health. The S&IP segment’s product portfolio includes sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves. The S&IP segment is also a provider of education to prevent healthcare-associated infections. The Medical Devices segment provides a portfolio of product offerings focused on pain management and respiratory and digestive health. Its products include QUICK CHECK, SMART-FOLD, POWERGUARD, MICROCOOL and FLUIDSHIELD.